Russell Howard Swerdlow
#133,614
Most Influential Person Now
Russell Howard Swerdlow's AcademicInfluence.com Rankings
Russell Howard Swerdlowbiology Degrees
Biology
#8984
World Rank
#12133
Historical Rank
Genetics
#906
World Rank
#1002
Historical Rank
Neuroscience
#1290
World Rank
#1335
Historical Rank
Download Badge
Biology
Russell Howard Swerdlow's Degrees
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is Russell Howard Swerdlow Influential?
(Suggest an Edit or Addition)Russell Howard Swerdlow's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) (716)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Origin and functional consequences of the complex I defect in Parkinson's disease (1996) (646)
- A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. (2004) (596)
- The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. (2014) (540)
- Mutations in the colony stimulating factor 1 receptor (CSF1R) cause hereditary diffuse leukoencephalopathy with spheroids (2011) (442)
- The Alzheimer's disease mitochondrial cascade hypothesis. (2010) (441)
- Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease (2017) (410)
- Complex I deficiency in Parkinson's disease frontal cortex (2008) (363)
- Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing (2020) (294)
- Pathogenesis of Alzheimer’s disease (2007) (283)
- Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. (1997) (275)
- Brain aging, Alzheimer's disease, and mitochondria. (2011) (273)
- Right orbitofrontal tumor with pedophilia symptom and constructional apraxia sign. (2003) (271)
- Reduced lean mass in early Alzheimer disease and its association with brain atrophy. (2010) (268)
- Abnormal Mitochondrial Morphology in Sporadic Parkinson's and Alzheimer's Disease Cybrid Cell Lines (2000) (263)
- Calcium Homeostasis and Reactive Oxygen Species Production in Cells Transformed by Mitochondria from Individuals with Sporadic Alzheimer’s Disease (1997) (250)
- Cybrids in Alzheimer's disease: A cellular model of the disease? (1997) (216)
- Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities (2019) (203)
- Heat Treatment Improves Glucose Tolerance and Prevents Skeletal Muscle Insulin Resistance in Rats Fed a High-Fat Diet (2009) (202)
- Mitochondria in Sporadic Amyotrophic Lateral Sclerosis (1998) (199)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
- Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial (2017) (193)
- The Alzheimer's disease mitochondrial cascade hypothesis: An update (2009) (193)
- Functional mitochondria are required for amyloid β‐mediated neurotoxicity (2001) (188)
- Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease. (2012) (179)
- Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease (2017) (173)
- Is Alzheimer's disease a systemic disease? (2014) (165)
- Regulation of neuron mitochondrial biogenesis and relevance to brain health. (2010) (165)
- Mitochondria in neurodegeneration. (2012) (165)
- DNA extraction procedures meaningfully influence qPCR-based mtDNA copy number determination. (2009) (164)
- Cardiorespiratory fitness and brain atrophy in early Alzheimer disease (2008) (164)
- Alzheimer's disease cybrids replicate β‐amyloid abnormalities through cell death pathways (2000) (162)
- Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell. (2014) (152)
- Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family (1998) (150)
- Oxidative stress involvement in alpha-synuclein oligomerization in Parkinson's disease cybrids. (2009) (136)
- Role of mitochondrial homeostasis and dynamics in Alzheimer's disease (2013) (136)
- Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies (2007) (130)
- Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? (2007) (127)
- Interaction Among Mitochondria, Mitogen‐Activated Protein Kinases, and Nuclear Factor‐κB in Cellular Models of Parkinson's Disease (2000) (126)
- Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines. (2013) (122)
- Amyloid precursor protein processing and bioenergetics (2017) (122)
- Mitochondria in Alzheimer's disease. (2002) (121)
- Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine (2006) (113)
- Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies (2014) (112)
- The Thiazolidinedione Pioglitazone Alters Mitochondrial Function in Human Neuron-Like Cells (2007) (108)
- Altered neurochemical profile after traumatic brain injury: 1H-MRS biomarkers of pathological mechanisms (2012) (105)
- Induction of cytochrome c-mediated apoptosis by amyloid β 25-35 requires functional mitochondria (2002) (105)
- Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases (2012) (104)
- The neurodegenerative mitochondriopathies. (2009) (101)
- Mitochondrial dysfunction in idiopathic Parkinson disease. (1998) (100)
- Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background. (2008) (97)
- Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease (2010) (97)
- Cardiorespiratory fitness is associated with atrophy in Alzheimer's and aging over 2 years (2012) (96)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (96)
- Use of Cytoplasmic Hybrid Cell Lines for Elucidating the Role of Mitochondrial Dysfunction in Alzheimer's Disease and Parkinson's Disease (1999) (95)
- Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. (1998) (95)
- Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases (2017) (94)
- Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways. (2000) (92)
- Neuroketotherapeutics: A modern review of a century-old therapy (2017) (91)
- Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery (2017) (90)
- LRRK2, a puzzling protein: Insights into Parkinson's disease pathogenesis (2014) (90)
- Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease (2011) (89)
- MRI characteristics and scoring in HDLS due to CSF1R gene mutations (2012) (87)
- Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease. (2015) (86)
- Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. (2020) (86)
- Effect of high-intensity exercise on aged mouse brain mitochondria, neurogenesis, and inflammation (2014) (83)
- Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture (2004) (82)
- Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease. (2011) (81)
- Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention. (2012) (80)
- A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults. (2017) (79)
- Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem. (2007) (79)
- Lactate administration reproduces specific brain and liver exercise‐related changes (2013) (79)
- Mitochondrial respiration and respiration‐associated proteins in cell lines created through Parkinson’s subject mitochondrial transfer (2010) (79)
- Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic (2012) (78)
- Altering O-Linked β-N-Acetylglucosamine Cycling Disrupts Mitochondrial Function* (2014) (77)
- Maternal transmission of Alzheimer's disease: Prodromal metabolic phenotype and the search for genes (2010) (77)
- Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation. (2014) (76)
- Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration (2017) (75)
- Mitochondria, Cybrids, Aging, and Alzheimer's Disease. (2017) (72)
- Further Evidence for Mitochondrial Dysfunction in Progressive Supranuclear Palsy (2001) (70)
- Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns (2017) (69)
- Oxaloacetate activates brain mitochondrial biogenesis, enhances the insulin pathway, reduces inflammation and stimulates neurogenesis. (2014) (68)
- Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging. (2012) (67)
- Mitochondrial lysates induce inflammation and Alzheimer's disease-relevant changes in microglial and neuronal cells. (2015) (65)
- Alzheimer’s Disease Pathologic Cascades: Who Comes First, What Drives What (2012) (63)
- Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production. (2010) (63)
- Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease. (2006) (61)
- Dysfunctional mitochondria uphold calpain activation: Contribution to Parkinson's disease pathology (2010) (59)
- Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans (2012) (59)
- Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease (2017) (58)
- Beyond amyloid: Getting real about nonamyloid targets in Alzheimer's disease (2013) (57)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (56)
- Gender ratio differences between Parkinson's disease patients and their affected relatives. (2001) (56)
- Mitochondrial DNA--related mitochondrial dysfunction in neurodegenerative diseases. (2002) (55)
- Sustained O-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism (2017) (55)
- Maternal family history is associated with Alzheimer's disease biomarkers. (2012) (54)
- High-field proton magnetic resonance spectroscopy reveals metabolic effects of normal brain aging (2014) (53)
- Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. (2013) (53)
- A novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr‐Tranebjaerg syndrome (2001) (52)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (52)
- Risk factors for schizophrenia [2] (multiple letters) (1999) (50)
- Microtubule Depolymerization Potentiates Alpha-Synuclein Oligomerization (2009) (50)
- Cell and animal models of mtDNA biology: progress and prospects. (2007) (47)
- Pharmacologic ascorbate induces neuroblastoma cell death by hydrogen peroxide mediated DNA damage and reduction in cancer cell glycolysis (2017) (47)
- Deletion of Nampt in Projection Neurons of Adult Mice Leads to Motor Dysfunction, Neurodegeneration, and Death (2017) (45)
- Biochemical Analysis of Cybrids Expressing Mitochondrial DNA from Contursi Kindred Parkinson's Subjects (2001) (44)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (44)
- Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis (2020) (43)
- Ubiquitin proteasome system in Parkinson's disease: A keeper or a witness? (2012) (43)
- Bioenergetic medicine (2014) (41)
- Glycolysis-respiration relationships in a neuroblastoma cell line. (2013) (41)
- Effect of exercise on mouse liver and brain bioenergetic infrastructures (2013) (41)
- Mitochondria and ubiquitin-proteasomal system interplay: relevance to Parkinson's disease. (2008) (40)
- Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies (2009) (39)
- Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients. (1999) (37)
- Oxaloacetate enhances neuronal cell bioenergetic fluxes and infrastructure (2016) (37)
- Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease: A Possible Connection (2014) (37)
- Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases. (2011) (37)
- Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease (2017) (36)
- Regulation of energy metabolism during early mammalian development: TEAD4 controls mitochondrial transcription (2018) (36)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (35)
- Ncb5or Deficiency Increases Fatty Acid Catabolism and Oxidative Stress* (2011) (34)
- Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer′s disease (2019) (34)
- Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients (2017) (33)
- Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells. (2016) (32)
- Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence. (2012) (32)
- Mitochondrial Dysfunction and Stress Responses in Alzheimer’s Disease (2019) (31)
- An Experimental Ketogenic Diet for Alzheimer Disease Was Nutritionally Dense and Rich in Vegetables and Avocado (2019) (30)
- Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial (2018) (30)
- Effects of memantine on mitochondrial function. (2008) (30)
- Bioenergetics and metabolism: a bench to bedside perspective (2016) (29)
- Extracellular Mitochondria and Mitochondrial Components Act as Damage-Associated Molecular Pattern Molecules in the Mouse Brain (2016) (29)
- The mitochondrial hypothesis: Dysfunction, bioenergetic defects, and the metabolic link to Alzheimer's disease. (2020) (29)
- Consumption of polyphenol plants may slow aging and associated diseases. (2013) (29)
- Dietary Neuroketotherapeutics for Alzheimer’s Disease: An Evidence Update and the Potential Role for Diet Quality (2019) (28)
- Polymorphic variation in cytochrome oxidase subunit genes. (2010) (28)
- A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement (2015) (28)
- Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits (2016) (28)
- Mitochondrial Haplotypes Associated with Biomarkers for Alzheimer’s Disease (2013) (27)
- SHORT‐TERM EFFECT OF DEMENTIA DISCLOSURE: HOW PATIENTS AND FAMILIES DESCRIBE THE DIAGNOSIS (2006) (26)
- Nerve growth factor attenuates oxidant‐induced β‐amyloid neurotoxicity in sporadic Alzheimer’s disease cybrids (2010) (26)
- Impaired fasting glucose is associated with increased regional cerebral amyloid (2016) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau (2020) (26)
- Regulation of Mitochondrial Function and Cellular Energy Metabolism by Protein Kinase C‐λ/ι: A Novel Mode of Balancing Pluripotency (2014) (25)
- A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial. (2017) (24)
- A cybrid cell model for the assessment of the link between mitochondrial deficits and sporadic Parkinson's disease. (2015) (24)
- Detection of mitochondria-pertinent components in exosomes. (2020) (21)
- Effect of one month duration ketogenic and non-ketogenic high fat diets on mouse brain bioenergetic infrastructure (2015) (21)
- 18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery (2018) (21)
- Is NADH Effective in the Treatment of Parkinson’s Disease? (1998) (20)
- Mitonuclear interactions influence Alzheimer’s disease risk (2019) (20)
- Role of mitochondria in amyotrophic lateral sclerosis (2000) (20)
- Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (20)
- Potentiation of dietary restriction-induced lifespan extension by polyphenols. (2012) (19)
- Polyunsaturated fatty acids mobilize intracellular Ca2+ in NT2 human teratocarcinoma cells by causing release of Ca2+ from mitochondria. (2006) (19)
- Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts (2020) (19)
- Molecular characterization of mtDNA depleted and repleted NT2 cell lines. (2005) (19)
- The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis (2022) (19)
- A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data (2019) (19)
- Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease (2006) (18)
- Arsenite Effects on Mitochondrial Bioenergetics in Human and Mouse Primary Hepatocytes Follow a Nonlinear Dose Response (2017) (18)
- Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects (2016) (18)
- Fatal encephalitis in a patient with refractory celiac disease presenting with myorhythmia and carpal spasm (2007) (17)
- Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021) (16)
- Proteomic Analysis and Biochemical Correlates of Mitochondrial Dysfunction after Low-Intensity Primary Blast Exposure. (2019) (16)
- Alternate day fasting impacts the brain insulin‐signaling pathway of young adult male C57BL/6 mice (2011) (16)
- Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploring. (2014) (16)
- Mitochondrial links between brain aging and Alzheimer’s disease (2021) (15)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (15)
- Autosomal dominant subcortical gliosis presenting as frontotemporal dementia (2008) (14)
- Open-source, Rapid Reporting of Dementia Evaluations. (2018) (14)
- A bioenergetics systems evaluation of ketogenic diet liver effects. (2017) (14)
- A ketogenic diet differentially affects neuron and astrocyte transcription (2021) (13)
- Mitochondrial DNA Manipulations Affect Tau Oligomerization. (2020) (13)
- Calpain-mediated MPP+ toxicity in mitochondrial DNA depleted cells (2009) (13)
- Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study (2021) (12)
- Lactate's effect on human neuroblastoma cell bioenergetic fluxes. (2016) (12)
- A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease (2016) (12)
- PET sheds light on Alzheimer's disease genetic risk (2007) (11)
- Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery (2018) (11)
- Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients (2020) (10)
- Mitochondria and Alzheimer’s: Is PTCD1 the Smoking Gun? (2019) (10)
- The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum (2016) (10)
- β‐Apptists and Tauists, it is time for a sermon from the book of biogenesis (2012) (9)
- Bioenergetic and inflammatory systemic phenotypes in Alzheimer’s disease APOE ε4‐carriers (2021) (9)
- FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2020) (9)
- Effect of cholinergic signaling on neuronal cell bioenergetics. (2013) (9)
- Mitochondrial DNA depletion analysis by pseudogene ratioing (2006) (9)
- Alzheimer disease (2012) (9)
- Mitochondria and Parkinson's Disease (2012) (8)
- GRK5 Deficiency Leads to Selective Basal Forebrain Cholinergic Neuronal Vulnerability (2016) (8)
- A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease (2020) (8)
- Mitochondria and Free Radicals in Neurodegenerative Diseases (1998) (8)
- A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease (2022) (7)
- A globally diverse reference alignment and panel for imputation of mitochondrial DNA variants (2019) (7)
- Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization (2021) (7)
- Mitochondrial Membrane Potential Influences Amyloid-β Protein Precursor Localization and Amyloid-β Secretion (2021) (6)
- Healthy individuals with a family history of Alzheimer’s disease have increased default mode network activity (2015) (6)
- APOE, TOMM40, and sex interactions on neural network connectivity (2021) (6)
- Dystonia with and without deafness is caused by TIMM8A mutation. (2004) (6)
- Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice (2016) (6)
- Risk factors for schizophrenia. (1999) (6)
- Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume (2022) (6)
- The Brain Atlas: A Visual Guide to the Human Central Nervous System, 3rd Edition (2008) (6)
- Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal Muscle (2021) (5)
- Polyunsaturated fatty acids mobilize intracellular Ca 2 in NT 2 human teratocarcinoma cells by causing release of Ca 2 from mitochondria (2006) (5)
- Mild cognitive impairment: when nutrition helps brain energy rescue—a report from the EuGMS 2020 Congress (2021) (5)
- Mitochondrial function and Aβ in Alzheimer's disease postmortem brain (2022) (5)
- An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease (2022) (5)
- “Untangling” the relationship between Alzheimer disease and dementia with Lewy bodies (2012) (5)
- Current Status of Healthy Aging and Dementia Research: A Symposium Summary. (2019) (5)
- Backwaters and rapids on the amyloid river (2013) (5)
- Polyunsaturated fatty acids mobilize intracellular Ca in NT2 human teratocarcinoma cells by causing release of Ca from mitochondria (2006) (4)
- For Alzheimer disease GWAS, pulling needles from the haystack is just the first step (2012) (4)
- Mitochondria in Alzheimer brains (2020) (4)
- Dorsal Root Ganglia Mitochondrial Biochemical Changes in Non-diabetic and Streptozotocin-Induced Diabetic Mice Fed with a Standard or High-Fat Diet. (2017) (4)
- Investigation of Insulin Signaling in Parkinson's Disease Cytoplasmic Hybrid Cells (2010) (4)
- Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients (2022) (4)
- Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
- Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer’s Disease (2022) (4)
- Synaptosome microRNAs regulate synapse functions in Alzheimer’s disease (2021) (4)
- An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer’s Disease (2018) (4)
- Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease (2021) (4)
- The Role of Mitochondrial genome abundance in Alzheimer's Disease (2022) (3)
- TOMM40 '523 Associations with Baseline and Longitudinal Cognition in APOE ɛ3 Homozygotes. (2019) (3)
- Mitochondrial Manipulation and the Quest for Alzheimer's Treatments (2015) (3)
- Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord (2021) (3)
- Mitochondrial Targeting of Amyloid-β Protein Precursor Intracellular Domain Induces Hippocampal Cell Death via a Mechanism Distinct from Amyloid-β. (2022) (3)
- Effects of Microglial Cytokines on Alzheimer's Disease-Related Phenomena. (2019) (3)
- TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): INTERIM FDG PET ANALYSIS (2018) (3)
- An Alzheimer disease presenilin mutation, syndrome diversity, and a shrinking world (2010) (3)
- Rare ABCA7 variants in Alzheimer disease (2016) (3)
- Comment: BDNF, fitness, and the brain (2014) (2)
- Pharmacologic Enrichment of Exosome Yields and Mitochondrial Cargo. (2022) (2)
- Maternal age is not a risk factor for Parkinson's disease (2001) (2)
- A Pilot Study of Oxaloacetate 100 mg Capsules in Parkinson’s Disease Patients (2016) (2)
- Mitochondrial Dysfunction in Parkinson’s Disease: Potential Applications for Cybrid Modeling of the Disease (1998) (2)
- THE KU ALZHEIMER'S DISEASE KETOGENIC DIET FEASIBILITY AND RETENTION TRIAL: RESULTS FROM A PILOT STUDY (2017) (2)
- CONSENSUS: a Shiny application of dementia evaluation and reporting for the KU ADC longitudinal Clinical Cohort database (2020) (2)
- MAGNETIC RESONANCE SPECTROSCOPY INVESTIGATIONS OF EFFECTS OF GLUCOSE IN NORMAL AGING BRAIN (2014) (2)
- Betahydroxybutyrate Consumption in Autopsy Brain Tissue from Alzheimer’s Disease Subjects (2021) (2)
- EFFECTS OF OXALOACETATE TREATMENTS ON CEREBRAL ANTIOXIDANT AND NEUROCHEMICAL PROFILE IN PATIENTS WITH ALZHEIMER’S DISEASE USING IN VIVO METABOLIC NEUROIMAGING (2019) (1)
- Multimodal strategy to rescue the brain in mild cognitive impairment: Ketogenic oral nutrition supplementation with B vitamins and aerobic exercise (2022) (1)
- Induction of Bax-dependent neuronal apoptosis by Amyloid-β Protein Precursor (AβPP) requires its localization to functional mitochondria (2017) (1)
- Differential regulation of intracellular calcium oscillations by mitochondria and gap junctions (2006) (1)
- Blood Bioenergetic Biomarkers in Alzheimer’s Disease APOE ε4-Carriers (2020) (1)
- A Mitochondrial DNA Haplogroup Defines Patterns of Five-Year Cognitive Change. (2022) (1)
- Association of maternal family history of dementia with Alzheimer's disease biomarkers (2012) (1)
- ALZHEIMER’S DISEASE SUBJECTS EXHIBIT IMPAIRED SYSTEMIC GLUCOSE METABOLISM FOLLOWING A MIXED MEAL (2018) (1)
- VIGOROUS EXERCISE AFFECTS BRAIN MITOCHONDRIA, NEUROGENESIS, AND INFLAMMATION-RELATED PARAMETERS IN AGED MICE (2014) (1)
- A Multicenter Screening Trial of the Safety and Efficacy of Rasagiline in People with ALS (S36.006) (2013) (1)
- MITOCHONDRIAL GENETICS ’98 Mitochondrial Dysfunction in Idiopathic Parkinson Disease (1998) (1)
- TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS (2019) (1)
- Alzheimer Research Forum Live Discussion: A "Mitochondrial Cascade Hypothesis" for sporadic Alzheimer's disease (2005) (1)
- Mitochondrial Function and Neurodegenerative Diseases (2018) (1)
- Nonobese Male Patients with Alzheimer's Disease Are Vulnerable to Decrease in Plasma Leptin. (2022) (1)
- Association of Alzheimer’s disease progression with baseline clinical and genetic characteristics (2020) (1)
- Interplay between O‐GlcNAc and acetylation regulates mitochondrial function (756.7) (2014) (1)
- MitoImpute: A Snakemake pipeline for imputation of mitochondrial genetic variants (2019) (1)
- Mutations in the Amyloid-β Protein Precursor Reduce Mitochondrial Function and Alter Gene Expression Independent of 42-Residue Amyloid-β Peptide. (2021) (1)
- RESEARCH ON VIBRATORY-OUTPUT ANGULAR MOTION SENSORS. (1961) (0)
- Mitochondrial Membrane Potential Influences Aβ Production and Amyloid Precursor Protein localization (2021) (0)
- Does oxaloacetate preserve mitochondrial function in the aged brain? (2020) (0)
- Thiamet G effects on mitochondria and AD pathological hallmarks in human iPSC derived models (2021) (0)
- Mitochondria and Sporadic Neurodegenerative Disease (2012) (0)
- Books to Read Before You Graduate High School (2021) (0)
- Ncb5or deficiency increases fatty acid catabolism, oxidative stress and sensitivity to saturated fatty acid‐induced cytotoxicity (2011) (0)
- Information overload? Let a computer give you a hand. (1984) (0)
- IS NON-INVASIVE PROTON MAGNETIC RESONANCE SPECTROSCOPY SENSITIVE TO ALTERED BRAIN BIOENERGETICS? (2014) (0)
- P3‐228: WITHDRAWN (2018) (0)
- OPHTHALMIC BIOMARKER FOR MILD COGNITIVE IMPAIRMENTAND EARLY ALZHEIMER’S DISEASE (2019) (0)
- Effects of Microglial Cytokines on Alzheimer’s-Related Phenomena (2019) (0)
- P1-372: Lean mass is associated with cognition and brain atrophy in early Alzheimer's disease (2008) (0)
- AMYLOID BETA AND BIOENERGETICS (2019) (0)
- Observational Study for MRI Characteristics in HDLS with a Known Gene Mutation on Chromosome 5 (P06.180) (2012) (0)
- PLATELET MITOCHONDRIA CYTOCHROME OXIDASE AND CITRATE SYNTHASE IN APOE4-CARRIER AD SUBJECTS (2017) (0)
- Heat Shock Protein 72 Regulates Lipid Handling in Hepatocytes (2017) (0)
- MITOCHONDRIAL MEMBRANE POTENTIAL INFLUENCE ON PROCESSING AND LOCALIZATION OF APP (2018) (0)
- OGA Inhibition Alters Energetics and Nutrient Sensing in Alzheimer's Disease Cytoplasmic Hybrids. (2020) (0)
- PHENOTYPIC CHARACTERIZATION OF EARLY ONSET FAMILIAL AD ASSOCIATED WITH A PSEN1 L418F MUTATION (2014) (0)
- Location, location, location! (2007) (0)
- TOMM40 ‘523 GENE ASSOCIATED WITH COGNITIVE PERFORMANCE AMONG NON-APOE E4 CARRIERS (2018) (0)
- Changes in O‐GlcNAcylation Alter Mitochondrial Function (2021) (0)
- Biogenesis of mitochondria connects to the cell cycle (2012) (0)
- BIOENERGETIC BIOMARKERS IN APOE ε4-CARRIER AD SUBJECTS (2019) (0)
- MITOCHONDRIAL HAPLOGROUPS AND A NUCLEAR ENCODED MITOCHONDRIAL POLYGENIC RISK SCORE INTERACT TO INFLUENCE DEMENTIA RISK (2018) (0)
- EFFECT OF β-HYDROXYBUTYRATE ON NEURONS AND ASTROCYTES (2018) (0)
- Erratum: Differential regulation of intracellular calcium oscillations by mitochondria and gap junctions (Cell Biochemistry and Biophysics 44, 2 (187-203)) (2006) (0)
- Mitochondrial pathway polygenic risk scores are associated with Alzheimer’s Disease (2020) (0)
- Of Mice and Men and the Search for an Alzheimer's Disease Treatment (2010) (0)
- Influence of mitochondrial function and cell bioenergetics on app processing (2015) (0)
- Relationship between cholinergic signaling and cell bioenergetics (2012) (0)
- A Vibratory Acoustic Gyroscope (1962) (0)
- PROTECTION AGAINST AB-INDUCED NEURONAL DAMAGE BY AN HSP90 C-TERMINAL MODULATOR: IMPORTANCE OF PYRUVATE DEHYDROGENASE KINASE (2018) (0)
- Is The Decrease In PGC1α Detected In ALS Patients An Up Stream Effector Or A Byproduct Of Mitochondrial Dysfunction? (P1.086) (2014) (0)
- Ninety‐day ketogenic diet intervention has differential effects on neuronal and astrocytic transcriptional pathways in mouse brain (2020) (0)
- O‐GlcNAc is Critical for the Regulation of Energy Metabolism (2017) (0)
- Injecting mitochondria into mouse hippocampi induces neuroinflammation and raises app expression (2015) (0)
- Maternal Family History of Alzheimer's Disease Predisposes to Increased Rate of Hippocampal Atrophy: an ADNI Study (2010) (0)
- MTDNA HAPLOGROUP ASSOCIATIONS WITH ALZHEIMER’S DISEASE RISK (2018) (0)
- Brain biomarkers derived by proton magnetic resonance spectroscopy may indicate brain energetic changes in Alzheimer’s disease (643.12) (2014) (0)
- IC-P1-005: Lean mass is associated with cognition and brain atrophy in early Alzheimer's disease (2008) (0)
- MITOCHONDRIA AND MITOCHONDRIAL DNA INDUCE NEUROINFLAMMATION AND ALTER APP HOMEOSTASIS (2016) (0)
- RESPIRATORY CHAIN INCOMPETENCE ALTERS TAU HOMEOSTASIS (2018) (0)
- INFLUENCE OF CELL BIOENERGETICS ON APP PROCESSING (2016) (0)
- HDLS: Due to CSF1R Gene Mutation; Clinical Characteristics (P05.119) (2012) (0)
- EVIDENCE FOR LINKAGE BETWEEN COGNITIVE DECLINE AND APOE- ɛ4 AND TOMM40 POLYMORPHISMS (2014) (0)
- RELATIONSHIP BETWEEN APOLIPOPROTEIN E4 GENOTYPE AND WHOLE BODY AEROBIC CAPACITY (2016) (0)
- Editorial of special column on Drug targets and drug development for Alzheimer's disease (2022) (0)
- SKELETAL MUSCLE MITOCHONDRIAL FUNCTION IN COGNITIVELY HEALTHY ELDERLY AND MCI SUBJECTS (2019) (0)
- Safety and target engagement profile of two oxaloacetate doses in Alzheimer’s patients (2020) (0)
- Elevated O‐GlcNAcylation levels improve mitochondrial function (2016) (0)
- Does TBI Affect mtDNA Heteroplasmy (2019) (0)
- Longer TOMM40 poly‐T variants associated with less regional gray matter in cognitively normal older APOE E3/E3 adults (2020) (0)
- IMPACT OF OXALOACETATE ON BRAIN BIOENERGETIC INFRASTRUCTURES, NEUROGENESIS, AND INFLAMMATION (2014) (0)
- APOE, TOMM40, and Sex Interactions on Neural Network Connectivity (2021) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- 40 Altered axonal transport of mitochondria in transmitochondrial cybrids from patients with sporadic Parkinson’s disease or a G11778A ND4 gene mutation (2007) (0)
- Cybrids in Alzheimer's disease: A cellular model of the disease? (1998) (0)
- Role of genetic variation on longitudinal imaging measures of Alzheimer's disease in the ADNI Cohort (2013) (0)
- Longer TOMM40 poly‐T variants associated with decreased regional gray matter in cognitively normal older APOE E3/E3 adults (2020) (0)
- Mitochondrial genetic variation is associated with brain imaging markers of Alzheimer's disease neurodegeneration (2013) (0)
- P3-022 NEUROTROPHIN SINGLE NUCLEOTIDE POLYMORPHISMS AND COGNITIVE FUNCTIONING IN OLDER ADULTS: THE CACHE COUNTY STUDY (2015) (0)
- PLATELET AND LYMPHOCYTE MITOCHONDRIAL BIOMARKERS IN APOE ε4-CARRIER AD SUBJECTS (2018) (0)
- Systemic metabolic abnormalities in Alzheimer's disease (2009) (0)
- TRIAL OF S-EQUOL IN ALZHEIMER’S DISEASE (SEAD) (2016) (0)
- Parkinson disease in twins. (1999) (0)
- Family history of dementia predicts cognitive decline in cognitively normal subjects (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Russell Howard Swerdlow?
Russell Howard Swerdlow is affiliated with the following schools:
